The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

50 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Continued optimization of the MEBI
Vanderbilt University School of Medicine
Development of thieno- and benzopyrimidinone inhibitors of the Hedgehog signaling pathway reveals PDE4-dependent and PDE4-independent mechanisms of action.EBI
Vanderbilt University School of Medicine
Discovery of 2-Indole-acylsulfonamide Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods.EBI
Vanderbilt University School of Medicine
Inhibition of human DNA topoisomerase IIa by two novel ellipticine derivatives.EBI
Vanderbilt University School of Medicine
Discovery of tricyclic indoles that potently inhibit Mcl-1 using fragment-based methods and structure-based design.EBI
Vanderbilt University School of Medicine
Diphenylpyrazoles as replication protein a inhibitors.EBI
Vanderbilt University School of Medicine
Discovery of (S)-2-cyclopentyl-N-((1-isopropylpyrrolidin2-yl)-9-methyl-1-oxo-2,9-dihydro-1H-pyrrido[3,4-b]indole-4-carboxamide (VU0453379): a novel, CNS penetrant glucagon-like peptide 1 receptor (GLP-1R) positive allosteric modulator (PAM).EBI
Vanderbilt University School of Medicine
Design of Fluorine-Containing 3,4-Diarylfuran-2(5H)-ones as Selective COX-1 Inhibitors.EBI
Vanderbilt University School of Medicine
Fragment-based screening of the bromodomain of ATAD2.EBI
Vanderbilt University School of Medicine
Discovery of a potent stapled helix peptide that binds to the 70N domain of replication protein A.EBI
Vanderbilt University School of Medicine
Discovery of a potent inhibitor of replication protein a protein-protein interactions using a fragment-linking approach.EBI
Vanderbilt University School of Medicine
Discovery of Protein-Protein Interaction Inhibitors of Replication Protein A.EBI
Vanderbilt University School of Medicine
Development of potent and selective indomethacin analogues for the inhibition of AKR1C3 (Type 5 17ß-hydroxysteroid dehydrogenase/prostaglandin F synthase) in castrate-resistant prostate cancer.EBI
Vanderbilt University School of Medicine
Discovery of potent myeloid cell leukemia 1 (Mcl-1) inhibitors using fragment-based methods and structure-based design.EBI
Vanderbilt University School of Medicine
Development of an in vivo active, dual EP1 and EP3 selective antagonist based on a novel acyl sulfonamide bioisostere.EBI
Vanderbilt University School of Medicine
Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes.EBI
Vanderbilt University School of Medicine
Mibefradil is a P-glycoprotein substrate and a potent inhibitor of both P-glycoprotein and CYP3A in vitro.EBI
Vanderbilt University School of Medicine
Modulation by drugs of human hepatic sodium-dependent bile acid transporter (sodium taurocholate cotransporting polypeptide) activity.EBI
Vanderbilt University School of Medicine
Further optimization of the K-Cl cotransporter KCC2 antagonist ML077: development of a highly selective and more potent in vitro probe.EBI
Vanderbilt University School of Medicine
Generation of new protein kinase inhibitors utilizing cytochrome p450 mutant enzymes for indigoid synthesis.EBI
Vanderbilt University School of Medicine
Podophyllotoxin analogues active versus Trypanosoma brucei.EBI
Vanderbilt University School of Medicine
The influence of double bond geometry in the inhibition of cyclooxygenases by sulindac derivatives.EBI
Vanderbilt University School of Medicine
Discovery of VU0467485/AZ13713945: An MEBI
Vanderbilt University School of Medicine
Substituent effects of N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamides on positive allosteric modulation of the metabotropic glutamate-5 receptor in rat cortical astrocytes.EBI
Vanderbilt University School of Medicine
Fragment-Based Discovery of Small Molecules Bound to T-Cell Immunoglobulin and Mucin Domain-Containing Molecule 3 (TIM-3).EBI
Vanderbilt University School of Medicine
Discovery of a novel class of heteroaryl-pyrrolidinones as positive allosteric modulators of the muscarinic acetylcholine receptor MEBI
Vanderbilt University School of Medicine
Harmaline Analogs as Substrate-Selective Cyclooxygenase-2 Inhibitors.EBI
Vanderbilt University School of Medicine
Targeted Detection of Cyclooxygenase-1 in Ovarian Cancer.EBI
Vanderbilt University School of Medicine
Enantiospecific, selective cyclooxygenase-2 inhibitors.EBI
Vanderbilt University School of Medicine
Amide derivatives of meclofenamic acid as selective cyclooxygenase-2 inhibitors.EBI
Vanderbilt University School of Medicine
VU6005806/AZN-00016130, an advanced MEBI
Vanderbilt University School of Medicine
Discovery of Sulfonamide-Derived Agonists of SOS1-Mediated Nucleotide Exchange on RAS Using Fragment-Based Methods.EBI
Vanderbilt University School of Medicine
Multistep Binding of the Non-Steroidal Inhibitors Orteronel and Seviteronel to Human Cytochrome P450 17A1 and Relevance to Inhibition of Enzyme Activity.EBI
Vanderbilt University School of Medicine
Discovery and SAR of a novel series of potent, CNS penetrant M4 PAMs based on a non-enolizable ketone core: Challenges in disposition.EBI
Vanderbilt University School of Medicine
Ester and amide derivatives of the nonsteroidal antiinflammatory drug, indomethacin, as selective cyclooxygenase-2 inhibitors.EBI
Vanderbilt University School of Medicine
Discovery of an Orally Bioavailable and Central Nervous System (CNS) Penetrant mGluEBI
Vanderbilt University School of Medicine
Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human Cancer.EBI
Vanderbilt University School of Medicine
Validation of Human Sterol 14α-Demethylase (CYP51) Druggability: Structure-Guided Design, Synthesis, and Evaluation of Stoichiometric, Functionally Irreversible Inhibitors.EBI
Vanderbilt University School of Medicine
Discovery of Novel Central Nervous System Penetrant Metabotropic Glutamate Receptor Subtype 2 (mGluEBI
Vanderbilt University School of Medicine
Design, synthesis, and biochemical evaluation of N-substituted maleimides as inhibitors of prostaglandin endoperoxide synthases.EBI
Vanderbilt University School of Medicine
Sterol 14α-Demethylase Structure-Based Optimization of Drug Candidates for Human Infections with the Protozoan Trypanosomatidae.EBI
Vanderbilt University School of Medicine
Discovery of Quinazolines That Activate SOS1-Mediated Nucleotide Exchange on RAS.EBI
Vanderbilt University School of Medicine
Challenges in the development of an MEBI
Vanderbilt University School of Medicine
Design and Synthesis of EBI
Vanderbilt University School of Medicine
Sterol 14α-Demethylase Structure-Based Design of VNI (( R)- N-(1-(2,4-Dichlorophenyl)-2-(1 H-imidazol-1-yl)ethyl)-4-(5-phenyl-1,3,4-oxadiazol-2-yl)benzamide)) Derivatives To Target Fungal Infections: Synthesis, Biological Evaluation, and Crystallographic Analysis.EBI
Vanderbilt University School of Medicine
Discovery and optimization of 3-(4-aryl/heteroarylsulfonyl)piperazin-1-yl)-6-(piperidin-1-yl)pyridazines as novel, CNS penetrant pan-muscarinic antagonists.EBI
Vanderbilt University School of Medicine
Challenges in the development of an MEBI
Vanderbilt University School of Medicine
Optimization of Potent and Selective Tricyclic Indole Diazepinone Myeloid Cell Leukemia-1 Inhibitors Using Structure-Based Design.EBI
Vanderbilt University School of Medicine
Synthesis and evaluation of 4,6-disubstituted pyrimidines as CNS penetrant pan-muscarinic antagonists with a novel chemotype.EBI
Vanderbilt University School of Medicine
Acetylcholinesterase inhibitors for potential use in Alzheimer's disease: molecular modeling, synthesis and kinetic evaluation of 11H-indeno-[1,2-b]-quinolin-10-ylamine derivatives.BDB
University of Bologna